findmyKOL
Clinical trialNCT04868604RecruitingPhase 1/PHASE2Interventional

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

SponsorClarity Pharmaceuticals LtdEnrollment54Prostatic Neoplasms, Castration-Resistant
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford Cancer Institute

    Stanford, California, United States

    Hong Song, MD
    Recruiting
  • East Jefferson General Hospital

    River Ridge, Louisiana, United States

    Recruiting
  • Bamf Health

    Grand Rapids, Michigan, United States

    Brandon Mancini
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Geoffrey Johnson, MD
    Recruiting
  • Washington University School of Medicine at Barnes-Jewish Hospital

    St Louis, Missouri, United States

    Vikas Prasad, MD
    Recruiting
  • Xcancer

    Omaha, Nebraska, United States

    Luke Nordquist, MD
    Recruiting
  • Weill Cornell Medicine at New York-Presbyterian

    New York, New York, United States

    Scott Tagawa, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Aug 2021
Primary completion
30 Sept 2026
Completion
30 Sept 2026
Last update posted
6 May 2026
Registered enrollment
54
Registry id
NCT04868604
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.